Agnieszka Giza
Overview
Explore the profile of Agnieszka Giza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jaworek A, Sacha T, Wozniak-Knop M, Halubiec P, Giza A, Wojas-Pelc A
Pol Arch Intern Med
. 2024 Apr;
134(6).
PMID: 38640058
No abstract available.
2.
Witkowska M, Drozd-Sokolowska J, Waszczuk-Gajda A, Giza A, Lewicka B, Zdziarska J, et al.
Adv Clin Exp Med
. 2023 Nov;
33(10):1097-1104.
PMID: 38014929
Background: Autoimmune cytopenias (ACs), including immune thrombocytopenia (ITP), autoimmune hemolytic anemia (AIHA) and autoimmune granulocytopenia, are rare complications observed in lymphoma patients. They may appear before, during or after lymphoma...
3.
Pluta P, Giza A, Kolenda M, Fendler W, Braun M, Chudobinski C, et al.
Arch Med Sci
. 2023 Sep;
19(5):1243-1251.
PMID: 37732037
Introduction: Although breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is infrequent, with less than 1000 noted cases worldwide, patients consenting for breast implant surgery should be aware of its risk....
4.
Giza A, Miklusiak K, Halubiec P, Jaworek A, Zimowska-Curylo D, Dyduch G, et al.
Case Rep Dermatol
. 2023 Jul;
15(1):110-116.
PMID: 37497303
The large cell transformation of mycosis fungoides (MF-LCT) is a phenomenon observed in the advanced stages of mycosis fungoides (MF), which is the most common primary cutaneous lymphoma. The diagnostic...
5.
Paszkiewicz-Kozik E, Hus I, Palka M, Debowska M, Konska A, Kotarska M, et al.
Adv Clin Exp Med
. 2023 Jan;
32(1):131-136.
PMID: 36603138
Background: The first-line obinutuzumab-based immunochemotherapy improves the outcome of patients with follicular lymphoma (FL) compared with rituximab-based regimens. However, infusion-related reactions occur in almost half of patients during the 1st...
6.
Kalicinska E, Giza A, Zaucha J, Giebel S, Zimowska-Curylo D, Andrasiak I, et al.
Cancer Med
. 2022 Sep;
12(3):3036-3045.
PMID: 36161781
Objective: To investigate the prevalence of histopathological subtypes, the clinical stage at presentation and treatment modalities in Polish patients with orbital lymphoma (OL) and to determine prognostic outcomes. Methods: The...
7.
Wawrzycka-Adamczyk K, Matyja-Bednarczyk A, Giza A, Chmura L, Kosalka-Wegiel J, Bazan-Socha S
Pol Arch Intern Med
. 2022 Jan;
132(5).
PMID: 35089678
No abstract available.
8.
Swoboda R, Giebel S, Knopinska-Posluszny W, Chmielowska E, Drozd-Sokolowska J, Paszkiewicz-Kozik E, et al.
Ann Hematol
. 2021 Mar;
100(7):1919.
PMID: 33760951
No abstract available.
9.
Swoboda R, Giebel S, Knopinska-Posluszny W, Chmielowska E, Drozd-Sokolowska J, Paszkiewicz-Kozik E, et al.
Ann Hematol
. 2021 Feb;
100(7):1755-1767.
PMID: 33625572
The optimal salvage therapy in relapsed/refractory Hodgkin lymphoma (R/R HL) has not been defined so far. The goal of this multicenter retrospective study was to evaluate efficacy and safety of...
10.
Gora M, Czopek A, Rapacz A, Giza A, Koczurkiewicz-Adamczyk P, Pekala E, et al.
ChemMedChem
. 2021 Feb;
16(10):1619-1630.
PMID: 33539029
The aim of this study was to design and synthesize two new series of pyrrolidine-2,5-dione-acetamides with a benzhydryl or sec-butyl group at position 3 as potential anticonvulsants. Their anticonvulsant activity...